Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | THRB | P10828 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PFKFB3 | Q16875 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL787854 | 0.87 | PTPN1 (0.55) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL15912346 | 0.77 | PTPN1 (0.55) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL28883966 | 0.75 | PTPN1 (0.54) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL22515652 | 0.75 | PTPN1 (0.54) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL10216166 | 0.73 | PTPN1 (0.44) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL19499076 | 0.72 | PTPN1 (0.51) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL25146363 | 0.70 | MAPT (0.59) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL28603006 | 0.70 | PTPN1 (0.64) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL17615540 | 0.69 | PTPN1 (0.47) | PTPN1MAPTTHRBTP53SMN1; SMN2 | |
| SCHEMBL28238868 | 0.69 | PTPN1 (0.48) | PTPN1MAPTTHRBTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305173-A1 | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305173-A1 | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES | STS, PRSS1, PRSS3 | PTPN1 2171/4885MAPT 2196/4885THRB 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.